Table 2.

Correlation of CSE expression with clinicopathological characteristics in the discovery cohort-NDMCⁱ.

	CSE expression
	High RIa	Low RIa	P valueb
	N = 18	N = 117
Age
56<	9	66	0.61
55≥	9	51
FIGO stagec
III	15	85	0.402
IV	3	32
Histological typed
Serous	1	86	<0.0001
Clear cell	14	11
Endometrioid	1	9
Mucinous	2	11
Histological gradee
1 or 2	3	37	0.1957
3	15	80
Response to chemotherapyf
Responders (CR/PRg)	1	42	<0.0001
Non-responders (SD/PDh)	10	22

^aReactive intensity scores of automated quantitative virtual immunofluorescence pathology (AQVIP).

^bCalculated by Chi-squared or Fisher exact test.

^cAccording to the International Federation of Gynecology and Obstetrics (FIGO) staging system.

^dAccording to the World Health Organization (WHO) criteria.

^eAccording to Silverberg grading.

^fAccording to the Response Evaluation Criteria for Solid Tumors (RECIST) guidelines (version 1.1).

^gComplete response/partial response.

^hStable disease/progression disease.

ⁱFour patients, whose tissue cores which were designed on tissue microarray were worn after deep sectioning, were excluded from the analysis.